Prevention of neural tube defects in women taking additional supplements

22 Mar 2016, 2:57 p.m.

An ultrasound test is being conducted by a medical professional whose hand appears holding the device over what appears to be the belly of someone who is pregnant.

BRC-supported researchers Professors Andrew Copp and Nicholas Greene have led research which suggests that women who are at risk of having children with neural tube defects such as spina bifida may be able to reduce this risk by taking inositol (Vitamin B8) as well as folic acid during pregnancy.The study involved 99 women who had previously had a pregnancy affected by a neural tube defect, and who were planning on becoming pregnant within the next year. Half of these women agreed to be randomly assigned to one of two groups; one group were instructed to take 5 mg of Folic acid each day and a placebo, and the second group were instructed to take 5 mg of Folic acid plus 1 mg of Inositol daily. Among the women who chose not be randomised, many decided to take folic acid and inositol in their next pregnancy.

Overall, fifty-seven of the women became pregnant during the study period. Results showed that none of the women taking both inositol and folic acid had pregnancies with a neural tube defect, compared to three of those who took only folic acid.

This research suggests that for those women for whom folic acid supplements are not sufficient to prevent a neural tube defect, taking inositol in addition to folic acid, may provide greater protection. A larger-scale study is now needed in order to in order to confirm the beneficial effects of inositol.

The findings were published in the British Journal of Nutrition, and received media coverage from a number of different sources including the BBC.

World-first same-day metagenomics for children can detect hidden infections in intensive care

GOSH has successfully implemented a pioneering same-day respiratory metagenomics testing service for children in intensive care, helping clinicians identify infections more quickly and make better-informed treatment decision

GOSH families at the heart of major £6m project to improve support for children with complex needs

Children, young people and families from GOSH will help shape a major new research programme

Thousands join world-first trial to save lives of critically ill children

Some of the sickest children in the UK have started to join an innovative clinical trial designed to improve the survival and recovery of children requiring intensive care treatment, led by GOSH.

GOSH surgeon receives prestigious international award

Professor Paolo De Coppi, Consultant Paediatric Surgeon at Great Ormond Street Hospital (GOSH), has been recognised as an Honorary Fellow of the American College of Surgeons (ACS), one of the most prestigious honours in global surgery.